Ritu Salani

3PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 22, 2025
Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.

Stéphanie Gaillard, Christina Lacchetti, Deborah K Armstrong

|Jan 17, 2025
Real-world outcomes of first-line maintenance niraparib monotherapy in patients with epithelial ovarian cancer.

Ritu Salani, Tirza Areli Calderón Boyle, Jonathan Lim

|Jun 10, 2024
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).

Ritu Salani, Mary McCormack, Yong-Man Kim

Pageof 1